Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes.

Blood - 15 Aug 1994

Lublin D M, Mallinson G, Poole J, Reid M E, Thompson E S, Ferdman B R, Telen M J, Anstee D J, Tanner M J

Abstract excerpt

The human erythrocyte blood group system Cromer consists of high-incidence and low-incidence antigens that reside on decay-accelerating factor (DAF; CD55), a glycosyl-phosphatidylinositol-anchored membrane protein that regulates complement activation on cell surfaces. In the Cromer phenotypes Dr(a-) and Inab there is reduced or absent expression of DAF, respectively. This study investigated the molecular basis of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Sequence
Share to Antibodies, Monoclonal

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Antigens, CD

Share to Base Sequence

Share to Gene Expression

Share to Membrane Glycoproteins

Share to Molecular Sequence Data

Source

Identifiers

PMID: 7519480

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes.PMID 7519480Read ↗

Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants.Semantic proximity Read ↗

Novel molecular basis of an Inab phenotype.Semantic proximity Read ↗

Molecular cloning and characterization of decay-accelerating factor deficiency in Cromer blood group Inab phenotype.Semantic proximity Read ↗

Decay-accelerating factor (CD55) deficiency phenotypes in Japanese.Semantic proximity Read ↗

Molecular mapping of the Cromer blood group Cra and Tca epitopes of decay accelerating factor: toward the use of recombinant antigens in immunohematology.Semantic proximity Read ↗

Acquired and transient RBC CD55 deficiency (Inab phenotype) and anti-IFC.Semantic proximity Read ↗

A DOB allele encoding an amino acid substitution (Phe62Ser) resulting in a Dombrock null phenotype.Semantic proximity Read ↗

Biochemical studies on red blood cells from a patient with the Inab phenotype (decay-accelerating factor deficiency).Semantic proximity Read ↗

Glycosyl phosphatidylinositol-linked blood group antigens and paroxysmal nocturnal hemoglobinuria.Semantic proximity Read ↗

CD55-deficiency in Jews of Bukharan descent is caused by the Cromer blood type Dr(a-) variant.Semantic proximity Read ↗

Molecular basis of the Dombrock null phenotype.Semantic proximity Read ↗

Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.